US 12,214,204 B1
Movement disorder therapy system, devices and methods of remotely tuning
Dustin A Heldman, Shaker Heights, OH (US); Joseph P Giuffrida, Hinckley, OH (US); and Thomas O Mera, Columbus, OH (US)
Assigned to Great Lakes NeuroTechnologies Inc., Cleveland, OH (US)
Filed by Great Lakes NeuroTechnologies Inc., Cleveland, OH (US)
Filed on Sep. 14, 2023, as Appl. No. 18/368,050.
Application 18/368,050 is a continuation of application No. 17/324,255, filed on May 19, 2021, granted, now 11,786,735.
Application 17/324,255 is a continuation of application No. 15/016,816, filed on Feb. 5, 2016, granted, now 11,040,203, issued on Jun. 22, 2021.
Application 15/016,816 is a continuation of application No. 14/022,323, filed on Sep. 10, 2013, granted, now 9,289,603, issued on Mar. 22, 2016.
Application 14/022,323 is a continuation in part of application No. 13/861,790, filed on Apr. 12, 2013, granted, now 9,393,418, issued on Jul. 19, 2016.
Application 14/022,323 is a continuation in part of application No. 13/918,948, filed on Jun. 15, 2013, granted, now 9,211,417, issued on Mar. 13, 2014.
Claims priority of provisional application 61/698,890, filed on Sep. 10, 2012.
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01); G16H 20/10 (2018.01); G16H 40/60 (2018.01)
CPC A61N 1/36139 (2013.01) [A61N 1/36067 (2013.01); G16H 20/10 (2018.01); G16H 40/60 (2018.01)] 20 Claims
OG exemplary drawing
 
1. A movement disorder therapy system comprising:
a movement disorder therapy device implanted into, attached to, or worn or carried by a subject and being operable according to adjustable therapy parameters, the therapy device being a drug delivery pump operable according to a first set of adjustable dosing parameters;
a movement disorder diagnostic (MD2) device comprising:
a) at least one physiological or movement sensor capable of generating a signal, and
b) at least one electronic component comprising at least a transmitter,
c) the MD2 device adapted to measure symptomatic movement of the subject to obtain movement data based at least in part on the generated signal from the at least one physiological or movement sensor,
d) the transmitter adapted to transmit the measured movement data;
a processor adapted to:
a) receive the transmitted measured movement data,
b) extract at least one kinematic feature from the measured movement data, and
c) process the at least one kinematic feature with a quantification algorithm to obtain at least one score corresponding to a quantified severity of the subject's movement disorder or at least one symptom of such movement disorder;
a display adapted to display the subject's measured movement data, the first set of adjustable dosing parameters, and/or the at least one score to an expert clinician, physician or technician for determination of a second set of adjustable dosing parameters based at least in part on the subject's measured movement data and/or the at least one score; and
an interface adapted for entering, either automatically with the processor or manually by the expert clinician, physician or technician, the second set of adjustable dosing parameters either:
a) into a programmer device in communication with the subject's therapy device, or
b) directly into the subject's therapy device,
such that the subject's therapy device operates under the second set of adjustable dosing parameters to supply or provide therapy to the subject under the second set of adjustable dosing parameters to provide altered therapy to the subject.